New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 19, 2012
10:06 EDTVRTXVertex INCIVEK sales likely to decline further, says Piper Jaffray
After the FDA forced Vertex to place a warning regarding fatal and non-fatal serious skin reactions on the boxes containing its INCIVEK HCV treatment, Piper Jaffray expects sales of the drug to decline further. The firm maintains a Neutral rating on the stock.
News For VRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2015
07:45 EDTVRTXVertex initiated with a Buy at Canaccord
Target $150.
April 9, 2015
10:48 EDTVRTXDeutsche compares PTC Therapeutics to Vertex, boosts target by $40
Subscribe for More Information
07:27 EDTVRTXPTC Therapeutics price target raised to $115 from $75 at Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use